We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Congenica aspires to fully enable the routine use of genomic medicine to support the diagnosis and characterisation of disease like rare disease and cancer using complex genomic data. The reduction DNA sequencing cost has made analysis of a patient’s genome a reality and the challenge now is the data interpretation. Congenica a provider of a diagnostic decision support software platform, Sapientia, which enable clinicians to interrogate the human genome to identify disease-causing variants.
A diagnosis removes the fear of the unknown, allowing a patient’s family to deal with the known and make informed decisions. There is also the potential for healthcare savings by avoiding unnecessary appointments, tests and interventions.
HQ in Cambridge, UK founded by the Wellcome Trust Sanger Institute and leaders from the NHS. Congenica was recently named as the genomic software partner for the NHS. Congenica is currently expanding into markets in US, China and beyond.